Articles by Disease (Lymphoma)

Treatment of Refractory p53 Mutation Large B-cell Lymphoma with Daratumumab and Venetoclax Followed by CAR-T Cell Therapy: Case Report and Animal Study

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 20
Page: 513-519
Author(s): Duanhao Gong, Jia Gu, Kuangguo Zhou and Wei Huang*

Frequency of Cancer Associated with Children and Adolescents

Journal: New Emirates Medical Journal
Volume: 5
Page: 1-4
Author(s): Zahra Tolou-Ghamari*

E2F1 Reduces Sorafenib’s Sensitivity of Esophageal Carcinoma Cells via Modulating the miR-29c-3p/COL11A1 Signaling Axis

Journal: Current Molecular Pharmacology
Volume: 17
Page: 1-25
Author(s): Zhifeng Ma, Ting Zhu, Haiyong Wang, Bin Wang, Linhai Fu and Guangmao Yu*

Fangchinoline, an Extract of the Stephania tetrandra S. Moore Root, Promoted Oxidative Stress-induced DNA Damage and Apoptosis and Inhibited Akt Signaling in Jurkat T Cells

Journal: Current Molecular Pharmacology
Volume: 17
Page: 1-11
Author(s): Yanxiong Shao, Chaoran Li, Guojun Miao and Yubo Xu*

Physalin B Reduces Tau Phosphorylation and Cell Apoptosis in HEK293 Cells by Activating FoxO1

Journal: Current Molecular Pharmacology
Volume: 17
Page: 1-10
Author(s): Wei Zhang, Yating Shi, Mingti Lv, Yimin Zhang, Wei Ren, Ruling Shi, Hecheng Wang* and Linlin Shan

Targeting Mutant-p53 for Cancer Treatment: Are We There Yet?

Journal: Current Molecular Pharmacology
Volume: 17
Page: 1-16
Author(s): Dhi Vya Lim, Wei Hwei Woo, Jing Xuan Lim, Xin Yee Loh, Hui Ting Soh, Seng Yung Adrian Lim, Zheng Yang Lee, Hui Yin Yow, Sharina Binti Hamzah, Renukha Sellappans and Jhi Biau Foo*

Peptides for Dual Targeting of ErbB1 and ErbB2: Blocking EGFR Cell Signaling Transduction Pathways for Cancer Chemotherapy

Journal: Current Molecular Pharmacology
Volume: 17
Page: 1-11
Author(s): Sunil Kumar Patnaik, Akey Krishna Swaroop, Palathoti Nagarjuna, Moola Joghee Nanjan and Moola Joghee Nanjan Chandrasekar*

Maprotiline Prompts an Antitumour Effect by Inhibiting PD-L1 Expression in Mice with Melanoma

Journal: Current Molecular Pharmacology
Volume: 17
Page: 1-12
Author(s): Lirui Liang, Yang Li, Yang Jiao, Chunjing Zhang, Mingguang Shao, Hanyu Jiang, Zunge Wu, Haoqi Chen, Jiaming Guo, Huijie Jia* and Tiesuo Zhao*

A Deeply Quiescent Subset of CML LSC depend on FAO yet Avoid Deleterious ROS by Suppressing Mitochondrial Complex I

Journal: Current Molecular Pharmacology
Volume: 17
Page: 1-19
Author(s): Nyam-Osor Chimge, Min-Hsuan Chen, Cu Nguyen, Yuqi Zhao, Xiwei Wu, Paulina Garcia Gonzalez, Heather Ogana, Samantha Hurwitz, Jia-Ling Teo, Xiaolong Chen, Juan Du, Victor Jin, Yong-Mi Kim, Masaya Ono, Rafael J. Argüello and Michael Kahn*

The Mediating Role of miR-451/ETV4/MMP13 Signaling Axis on Epithelialmesenchymal Transition in Promoting Non-small Cell Lung Cancer Progression

Journal: Current Molecular Pharmacology
Volume: 17
Page: 1-1
Author(s): Xue-Jiao Qian, Jing-Wen Wang, Jiang-Bo Liu and Xi Yu*